Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2020 Aug 19;10:13985. doi: 10.1038/s41598-020-70867-5

Nearest-neighbor amino acids of specificity-determining residues influence the activity of engineered Cre-type recombinases

Anjali Soni 1, Martina Augsburg 2, Frank Buchholz 2, M Teresa Pisabarro 1,
PMCID: PMC7438526  PMID: 32814809

Abstract

The tyrosine-type site-specific DNA recombinase Cre recombines its target site, loxP, with high activity and specificity without cross-recombining the target sites of highly related recombinases. Understanding how Cre achieves this precision is key to be able to rationally engineer site-specific recombinases (SSRs) for genome editing applications. Previous work has revealed key residues for target site selectivity in the Cre/loxP and the related Dre/rox recombinase systems. However, enzymes in which these residues were changed to the respective counterpart only showed weak activity on the foreign target site. Here, we use molecular modeling and dynamics simulation techniques to comprehensively explore the mechanisms by which these residues determine target recognition in the context of their flanking regions in the protein–DNA interface, and we establish a structure-based rationale for the design of improved recombination activities. Our theoretical models reveal that nearest-neighbors to the specificity-determining residues are important players for enhancing SSR activity on the foreign target site. Based on the established rationale, we design new Cre variants with improved rox recombination activities, which we validate experimentally. Our work provides new insights into the target recognition mechanisms of Cre-like recombinases and represents an important step towards the rational design of SSRs for applied genome engineering.

Subject terms: Computational models, Protein design, Protein function predictions, Molecular engineering

Introduction

Site-specific DNA recombinases (SSRs) are powerful tools for precise DNA rearrangements to allow inversions, deletions and translocations in the genome of heterologous hosts14. The Cre/loxP recombinase system is a well-validated and extensively studied member of the tyrosine SSRs protein family5,6. The Cre enzyme (Causes recombination) from bacteriophage P1 is recognized as a prevalent tool for genetic alterations due to its efficiency and specificity to recombine its native DNA target sequence (loxP) and because of its simplicity of use, i.e. no accessory proteins are required for recombination catalysis5,7. Cre specifically recombines loxP, which is composed of two 13 base pair (bp) palindromic sequences parted by a spacer region of 8 bp (Fig. 1a)8. Each half-site of loxP is recognized by one Cre monomer. Cre-mediated recombination requires the formation of a synapse comprising a Cre tetramer recognizing two loxP sites. To start the recombination reaction, two Cre monomers in the tetrameric complex initiate the cleavage, whereas the other two are in an inactive or non-cleaving conformation1,5. The multi-step recombination event proceeds through the formation of a Holliday junction intermediate undergoing isomerization between the cleaving and non-cleaving conformations to complete reaction catalysis4.

Figure 1.

Figure 1

Nucleotides and amino acids at the protein-DNA interface of Cre/loxP and Dre/rox recombinase systems. (a) Sequences of loxP and rox target sites. The three nucleotides that differ between loxP and rox are highlighted in color. The numbering of the individual bases is provided for the upper and lower DNA strand, respectively. (b) Protein amino acids facing the altered DNA bases of loxP and rox. (c) Snapshot of the cleaving monomer of the Cre/loxP complex (PDB 1Q3U). The recognition regions at the protein-DNA interface are displayed in magenta (helix B), orange (helix D), green (helix J) and purple (beta 4). The area of interest in this study (i.e. PDIBJ area; the protein-DNA interface formed by amino acids of helix B and J and nucleotides 10/66, 11/65, and 12/64) is zoomed in, and relevant bases and amino acids are labeled. The numbering used is based on the Cre/loxP crystal structure (for details see Fig. S1). Figure generated using Pymol (version 2.1, https://pymol.org/).

SSRs have become indispensable for complex DNA manipulation due to their precise and unique ability to rearrange DNA both in vitro and in vivo, supporting many applications in biomedicine and biotechnology. To extend the utility of SSRs, recent efforts have focused on finding additional naturally occurring Cre-like SSRs and their respective target sites. The discovery of several such systems, including the Dre/rox9, VCre/VloxP10, SCre/SloxP10, Vika/vox11, Nigri/nox12 and Panto/pox12 recombinase systems has greatly expanded the repertoire of available SSRs that can be used alone or in combination to allow advanced genome engineering1315, and to build sophisticated synthetic biology circuits16,17. Importantly, while these enzymes, as well as their target sites, share high sequence similarities, cross-recombination is typically not observed. For instance, Cre shares 41% sequence identity with Dre, and their respective DNA target sites only differ in 3 out of the 13 bp per half-site (Fig. 1a). Nevertheless, Cre does not show activity on rox, and, similarly, Dre is inactive on loxP18. In previous work, detailed comparative analyses of these recombinases have identified the amino acids K43, R259, and G263 of Cre as critical residues for the discrimination between the loxP and rox sites12. Indeed, the substitution of these three amino acids in Cre by the corresponding Dre residues (mCreK variant: K43R, R259P, and G263K) (Fig. 1b) was sufficient to confer selectivity for rox, albeit at low activity. In order to establish a structure–function rationale, which could help in guiding further efforts for improving recombination properties, we decided to investigate in detail the molecular recognition mechanisms of these specificity-determinant key residues at positions 43, 259 and 263 in binding to loxP and rox sites.

Results and discussion

Based on the crystal structure of Cre bound to loxP in the synaptic state (PDB 1Q3U19), we generated three-dimensional (3D) molecular models of Dre/rox and mCreK in complex with loxP and rox target sites. Utilizing structure-based modeling and molecular dynamics (MD) simulations, we explored the interactions involved in protein-DNA binding in these complexes, particularly at the interface formed by the specificity-determining amino acids at positions 43, 259 and 263, which lay on helix B and J, and the nucleotides at positions 10/66, 11/65, and 12/64 (Fig. 1b,c). Hereafter, we named this interfacial region as the PDIBJ area.

MD-based recognition analysis of Cre/loxP

In order to better understand the molecular recognition mechanisms of the mCreK variant containing mutations at positions 43, 259 and 263 with respect to wild type Cre, we decided to first perform a comprehensive comparative analysis of the recognition properties of the wild type Cre/loxP and Dre/rox recombinase systems. For this purpose, we chose available structural information on the Cre/loxP synaptic complex obtained by X-ray crystallography (see “Materials and methods” for details) and performed MD simulations to examine at atomic detail the protein-DNA recognition and its binding energetics. Results obtained from the MD simulations underlined the crucial interactions prevalent in the Cre/loxP complex in the cleaving and non-cleaving conformers. The interactions observed for the cleaving conformer are shown in Figs. 2a and S1. The protein-DNA hydrogen bonds observed in our simulations are in agreement with those observed in the Cre/loxP crystal structure. Table S1 provides a comprehensive description of the hydrogen bonds observed in the MD trajectory based on their frequency of occurrence. At the investigated PDIBJ area (i.e. the interface formed by the specificity-determining amino acids at positions 43, 259, 263 of helix B and J, and bases at positions 10/66, 11/65, and 12/64, Fig. 1c), the residues K43, R259 and G263 recognize the central DNA base pairs C10/G66, G11/C65, T12/A64, and A13/T63 through direct hydrogen bonding (Fig. 2a). Residue K43 acts as a hydrogen-bond donor interacting with G11(N7 atom) in the major groove of the DNA (appearing in 73% of the simulation time, Fig. 2b and Table S1). Lysine may adopt different accessible rotamers in folded states of proteins20. As such, K43 can be found interacting dynamically with different bases in different crystal structures of Cre/loxP (i.e. with T63(O4) in PDB 1Q3U, and with G11(N7) in PDB 3C29). Our MD simulation predominantly supports the interaction with G11(N7). Residue R259 forms a strong bidentate hydrogen bond with the loxP bases G66(N7) (55% of the MD trajectory) and G66(O6) (40% of the MD trajectory) (Table S1). This interaction is crucial for Cre/loxP recognition21. Position 259 is particularly interesting from the recognition perspective in SSRs, as it can accommodate a variety of mutations to maintain specific contacts of different physico-chemical nature with the bases of the DNA target site22,23. Residue G263 provides stability to helix J by allowing E266 to interact with R259 (through its free NH1 atom) and therefore applying constraints to its orientation (Fig. 2b).

Figure 2.

Figure 2

Analysis of protein-DNA interactions in Cre/loxP (a) Projection of hydrogen bond interactions spotted in the last frame of the Cre/loxP MD trajectory. The base-specific interactions with the minor groove are labeled with an asterisk (*). Hashes (#) denote the interactions with the major groove. Nucplot was used to generate this image. (b) Detailed view of interactions observed in the Cre/loxP crystal structure and MD simulation in the PDIBJ area. Hydrogen bonds are shown in black dashed lines. The specificity-determining residues are highlighted with a yellow box. Water positions predicted by WaterMap (version 1.0, https://www.schrodinger.com/) are shown in orange spheres, and water-mediated contacts are depicted by orange lines. For comparison, a network of water molecules found in this area in another Cre/loxP crystal structure (PDB 3C29) is shown superimposed with the Cre/loxP MD-refined structure (cyan spheres and lines). Pymol was used to generate the image (version 2.1, https://pymol.org/).

Because water molecules can be crucial in defining the structure, function and stability of protein-DNA complexes2426, we also analyzed water-mediated contacts in the Cre/loxP complex using WaterMap27. The examination of the interfacial solvent indicated the presence of a water molecule in the major groove bridging the protein residue E262 to the base C65 (Fig. 2b). Interestingly, this predicted water-mediated contact coincides with an equivalent observed in another synaptic crystal structure of Cre/loxP (PDB 3C2928; Fig. 2b). Residue E262 is regarded as “guardian for loxP selectivity” as it is responsible for modulating DNA binding and discriminating loxP from other substrates4,29. We also observed a water-mediated protein–DNA interaction between the carboxylate group of E262 and the phosphates of the bases C65 and A64, which could point towards another preferential water-mediated contact not observed in the available crystallographic data, probably due to resolution restrictions. In view of the ion distribution in the Cre/loxP complex, a high density of K+ is observed in the DNA major groove of the investigated PDIBJ area, which could be linked to the presence of a GC-rich region, and in a lower extent in the loxP minor groove30,31 (Fig. S2a). Ions were also observed accumulating at the entrance of the major groove, as their presence will minimize the repulsion between residue E262 and DNA phosphates (see spatial location of E262 on helix J in Fig. 2b).

MD-based recognition analysis of Dre/rox

To perform a comprehensive comparative analysis, we investigated in detail the protein-DNA recognition properties in the Dre/rox recombinase system. For this purpose, we built a 3D molecular model of Dre in complex with rox by using available structural data at the Protein Data Bank (PDB32) on the Cre/loxP system as template and different software tools as validation for our modeling (see “Materials and methods” and Supplementary Information for details). The comparison of the resulting 3D Dre/rox models obtained by different means (i.e. MODELLER/Discovery Studio (DS)33,34 and the SWISS-MODEL35 and PHYRE236 webservers) with respect to the Cre/loxP structure showed similar RMSD’s values and, therefore structural agreement substantiating our modeling (i.e. heavy-atom RMSD of 1.59, 1.56 and 1.60 Å respectively, Fig. S3). For further studies, we chose the model obtained from DS.

The MD-based analysis of the obtained Dre/rox model indicated important amino acids involved in molecular recognition through hydrogen bond interactions with the DNA minor groove (H243, R244, R282) and major groove (R43, D44, K90) (Figs. 3a and S1). In comparison to Cre/loxP, the Dre/rox complex provides a modified interaction profile with less base-specific and more non-specific contacts (i.e. DNA backbone) (Figs. 3a and S1). A comprehensive description of the hydrogen bonds observed in the MD trajectory based on their frequency of occurrence is provided in Table S2.

Figure 3.

Figure 3

Analysis of protein-DNA interactions observed in the MD simulation of Dre/rox (a) Projection of hydrogen bond interactions spotted in the last frame of the Dre/rox MD trajectory. The base-specific interactions with the minor groove are labeled with an asterisk (*). Hashes (#) denote the interactions with the DNA major groove. Nucplot was used to generate the image. (b) Detailed view of interactions observed in the PDIBJ area of the Dre/rox complex based on MD simulations. The specificity-determining residues are highlighted with a yellow box. Hydrogen bonds are shown in black dashed lines and van der Waals interactions in dotted spheres. Pymol was used to generate the image (version 2.1, https://pymol.org/).

In the Dre/rox complex, residues R43, P259 and K263 were predicted to recognize the three bp T10/A66, A11/T65, A12/T64 and A13/T63 through a combination of hydrogen bonds and van der Waals contacts (Fig. 3b). Residue R43 was found to act as a hydrogen-bond donor interacting with O4 of T63 (at ~ 70% and 14% frequency of occurrence for atoms R43(NH1) and R43(NH2), respectively) (Fig. 3b and Table S2). Residue P259 established hydrophobic contacts with the methyl groups of T9 and T65 consequently forming a well-packed interface at the major groove of rox. Alanine at position 258 was also found to be contributing partially to these hydrophobic contacts. Residue K263 did not interact with any particular amino acid or base. With the presence of Proline at position 259 and Serine at position 266, an intra-helical contact between these residues was not observed in the Dre/rox complex. In comparison, in the Cre/loxP complex, residue E266 locks the orientation of R259 by forming a hydrogen bond and thus contributing to stabilizing the helix (Figs. 2b, 3b). However, this stabilization of the helix in the Dre/rox complex is provided by R284 (L284 in Cre), which interacts through hydrogen bonds with E262 and with the phosphate of T65. Water-mediated interactions were not observed in the PDIBJ area of the Dre/rox complex. Unlike Cre/loxP, the Dre/rox complex lacks the K+ density at the major groove of the DNA. As this complex also contains glutamic acid at position 262, the high K+ density is observed at the entrance of the major groove to minimize the repulsion between the respective amino acid and DNA phosphates (Fig. S2b).

MD-based comparative recognition analyses of mCreK/loxP and mCreK/rox

We next modeled the 3D structure of mCreK (K43R, R259P and G263K) in complex with loxP and with rox in order to establish a structure–function rationale that could guide further engineering of mCreK with improved activity on rox. The obtained mCreK/loxP and mCreK/rox complex structures were energy refined by MD simulations (see “Materials and methods” section for details). In the mCreK/loxP complex, R43 was observed to form bifurcated hydrogen bonding with N7 of G11 and O4 of T12, whereas in the mCreK/rox complex R43 interacted with the DNA backbone (Fig. 4a,b). Residue P259 formed compact van der Waals packing with the methyl groups of bases T65 and T64 on rox, along with residue T258. This compactness is missing in the complex with loxP due to the lack of those methyl groups in the altered bp C65 and A64 (Fig. 1a). Additionally, T258 was interacting with E262 in the mCreK/rox complex via hydrogen bonding. Residue K263 was observed to establish interactions with E266 in both mCreK/loxP and mCreK/rox complexes. However, a water-mediated contact was observed in the mCreK/loxP complex bridging E262 and the DNA backbone, while no such contact was detected in the mCreK/rox complex (Fig. 4). Altogether, the mCreK/loxP complex exhibited fewer interactions in the PDIBJ area than mCreK/rox, providing a rationale for the altered selectivity of mCreK on loxP and rox. The ion distributions in these complexes are presented in Fig. S2c and d. In the mCreK/loxP complex, a high K+ density is observed near the entrance of the major groove as mentioned above for the Cre/loxP complex, which could be associated to the presence of a GC-rich area, whereas in the mCreK/rox complex K+ density is observed only between the negatively charged groups of glutamic acid at position 266 and the DNA phosphates.

Figure 4.

Figure 4

Detailed view of interactions observed in the (a) mCreK/loxP complex and (b) mCreK/rox complex at the PDIBJ area based on MD simulations. The mutated amino acids with respect to wild type Cre are labeled with a yellow box. The hydrogen bonds are shown in black dashed lines and the van der Waals interactions in dotted spheres. A predicted water position using WaterMap (version 1.0, https://www.schrodinger.com/) is represented by an orange sphere and its interactions in solid orange lines. Pymol was used to generate the image (version 2.1, https://pymol.org/).

Rational engineering of new Cre variants with enhanced activities on rox

The detailed analysis of the MD simulations suggested that amino acids on helix J other than those at positions 259 and 263 might play an important role in molecular recognition in the mCreK/rox complex. Therefore, we investigated in detail the possible implication in the recombination activity of residues in close proximity to specificity-determining ones in the PDIBJ area.

Based on the hypothesis that neighboring residues to those determining specificity could potentially be used to tune activity, we focused on investigating in detail their recognition properties in order to select candidate positions for the introduction of new functionalities that could help in the engineering of improved recombination activity on rox. In the mCreK/rox complex, amino acid T258 was observed to form a hydrogen bond with the acceptor groups of E262, which also forced the latter to point towards the rox major groove (Fig. 4b). Thus, we hypothesized that by breaking the hydrogen bond between residues T258 and E262, we could increase the non-polar interactions at the PDIBJ area by the reorientation of T258 towards the major groove and pushing E262 away from the groove. This way, E262 could then participate in interactions with K263 and/or with the DNA backbone and contribute towards stabilizing helix J. Hence, we decided to design several new variants of mCreK.

We designed a first new variant, mCre1, by introducing the mutation T258A in the mCreK structure, which consists of a change to the Dre equivalent residue (mCre1; K43R, R259P, G263K, T258A) (see “Materials and methods” for details). The MD-based analysis of the mCre1/rox complex showed that the side chain of A258 promotes hydrophobic interactions with the methyl group of DNA base T65 (Fig. 5a). In this mCre1 variant, residues R43 and P259 were interacting with DNA bases T10 and A67, respectively, in a similar fashion as observed in the mCreK/rox complex (Figs. 4b, 5a). As hypothesized from our structure-based rationale, residue E262 was relocated pointing away from the groove and interacting with K263, and thus providing stability to the helix J. This displacement of E262 created a little void in the groove, which allowed the incorporation of a side chain bulkier than alanine at position 258. Therefore, we designed a second variant, mCre2, by introducing the mutation T258L (mCre2; K43R, R259P, G263K, T258L). The analysis of the results obtained in the MD simulation of mCre2/rox showed better packing in the groove by filling the void and involving T65 and T64 bases of rox while maintaining all the above-mentioned interactions (Fig. 5b). Next, while keeping the mutation T258L, and in order to further promote van der Waals and hydrophobic contacts, we designed another new mutant variant, mCre3, including the mutation E262L (mCre3; K43R, R259P, G263K, T258L, E262L). Simulation analysis of the mCre3/rox complex structure indicated that the mutations T258L and E262L had caused steric hindrance with the DNA bases and other protein residues, which enforced residues L258 and L262 to reorient and repack themselves with the adjacent hydrophobic residues L261, F265, I174 and A175 (Fig. 5c). Thereby, mCre3 resulted in a loose packing at the interface (Fig. 5c). To relieve possible steric repulsions, we designed a next variant, mCre4, in which position 262 was mutated to Isoleucine. Our molecular models indicated that the best counterpart for this change would be Alanine at position 258 (mCre4; K43R, R259P, G263K, T258A, E262I). Besides relieving the steric repulsions, we expected that these concurrent mutations in mCre4 would also provide some flexibility to helix J as noticed in the mCre1 variant (having T258A). The results obtained from the MD simulation analysis of the mCre4/rox complex showed the desired hydrophobic packing with the DNA bases A67, T65, and T64 (Fig. 5d). Overall, the mCre4/rox complex exhibited the highest number of interactions and the best packing complementarity. Water-mediated interactions were not observed in these newly engineered complexes. The ion distributions in these variants are shown in Fig. S2e–h. These variants also displayed high K+ densities between negatively charged E266 and DNA phosphates as observed in all the above complexes to minimize charge repulsion.

Figure 5.

Figure 5

Detailed view of interactions observed at the PDIBJ area in the MD simulations of the newly designed Cre variants with rox. (a) mCre1 (K43R, R259P, G263K, T258A) (b) mCre2 (K43R, R259P, G263K, T258L) (c) mCre3 (K43R, R259P, G263K, T258L, E262L) and (d) mCre4 (K43R, R259P, G263K, T258A, E262I). The mutated amino acids with respect to wild type Cre are labeled (yellow box). The hydrogen bonds are shown in black dashed lines and van der Waals interactions in dotted spheres. Pymol was used to generate the image (version 2.1, https://pymol.org/).

Interestingly, in our simulations we observed that when E262 is mutated to hydrophobic residues (i.e. Leucine and Isoleucine in mCre3 and mCre4, respectively), its role in binding to K263 is taken over by residue E266, thereby providing stability to helix J. This interaction was also observed in the mCreK/rox complex. The observation of mutating-neighboring residues taking over the role of indispensable residues has also been previously reported in evolved SSR systems37. Our MD-based analyses strongly emphasize on the relevance of having non-polar residues at certain neighboring positions in the PDIBJ area, which could possibly affect activity.

In our rationale, when we hypothesized the breaking of the hydrogen bond between T258 and E262 in the mCreK/rox complex, we proposed the simplest mutation of Threonine to Alanine at position 258 (as in mCre1 variant). As mentioned above, we then thoroughly investigated the impact of diverse amino acids on molecular recognition by introducing the mutation at position 258 alone and in combination with position 262, which led us to the use of hydrophobic residues i.e. Leucine and Isoleucine (as in mCre2, mCre3, and mCre4 variants). The MD analyses showed that the inclusion of these hydrophobic residues enhances the complementary packing at the DNA interface, mostly with the methyl groups of bases T65 and T66 in rox. The exception to this observation was the mCre3 variant. Coincidently, the sequence alignment of Cre, Dre and other related naturally occurring SSRs also revealed the presence of Alanine at position 258 in Dre and Panto, whereas the other SSRs present Threonine, Proline or Glutamic acid at this position (Fig. S4). However, none of the naturally occurring SSRs harbors bulky hydrophobic/non-polar residues at position 258 and/or 262. In fact, position 262 is occupied in most cases by charged/polar residues. This observation was particularly interesting for Dre and Panto, as they have Thymine as a base at positions 65 and 66 in their respective target sites. Our findings from the MD analysis of the new Cre variants underscore the presence of bulky hydrophobic groups at positions 258 and 262 with respect to rox. We further decided to investigate these findings energetically.

MD-based energetic analyses

In order to gain a deeper understanding on the recognition properties of the selected mutations and their potential effect on recombination activities, we estimated binding energies of all the respective protein-DNA complexes (mCreK/loxP, mCreK/rox, mCre1/rox, mCre2/rox, mCre3/rox and mCre4/rox). For this purpose, we performed a comparative energetic analysis of the mutant variants with respect to the wild type complexes (Cre/loxP, Dre/rox) utilizing MM-GB/PBSA38. The predicted MM-GB/PBSA binding energy of the Cre/loxP complex was higher than for the Dre/rox complex (− 662.61/− 781.01 versus − 465.78/− 577.23 kcal/mol), which is due to its greater number of contacts (Table 1 and Fig. S1). The calculated MM-GB/PBSA energies also reflected stronger binding of mCreK to rox than to loxP (− 657.54/− 785.05 and − 632.64/− 772.92 kcal/mol, respectively), as observed in the MD-based molecular analyses of the corresponding complexes.

Table 1.

Calculated MM-GB/PBSA binding energies and corresponding standard deviations (kcal/mol) for the studied SSRs complexes.

Complexes ΔEvdW ΔEele ΔGGB ΔGPB ΔGSA(GB) ΔGSA(PB) ΔGGBSA ΔGPBSA
Cre/loxP − 533.3 ± 16.6 − 28,163.6 ± 274.2 28,110.2 ± 266.9 27,973.5 ± 266.1 − 75.8 ± 1.4 − 57.5 ± 0.6 − 662.6 ± 31.4 − 781 ± 29.2
Dre/rox − 461.3 ± 15 − 21,026.5 ± 295 21,087.2 ± 282.1 20,962.0 ± 281.7 − 65.1 ± 1.6 − 51.4 ± 0.9 − 465.7 ± 33.8 − 577.2 ± 28.3
mCreK/loxP − 494.9 ± 14.3 − 27,939.3 ± 337.8 27,873.7 ± 336.2 27,716.1 ± 331.1 − 72.1 ± 1.5 − 54.7 ± 0.9 − 632.6 ± 26.6 − 772.9 ± 24.4
mCreK/rox − 519.3 ± 16.2 − 27,065.7 ± 286.6 27,003.1 ± 283.5 26,886.9 ± 288.9 − 75.6 ± 1.7 − 56.9 ± 0.8 − 657.5 ± 27.4 − 785.0 ± 26.1
mCre1/rox − 510.0 ± 25.5 − 27,428.3 ± 330.7 27,388.7 ± 331 27,212.2 ± 334.8 − 72.1 ± 2.3 − 55.4 ± 1.3 − 621.7 ± 24.8 − 781.5 ± 23.8
mCre2/rox − 515.7 ± 14.7 − 27,388.9 ± 290.4 27,358.3 ± 283 27,189.1 ± 288.1 − 72.8 ± 1.3 − 56.3 ± 0.8 − 619.1 ± 29.8 − 771.8 ± 33.4
mCre3/rox − 530.3 ± 16.5 − 28,623.0 ± 235.1 28,565.3 ± 223.5 28,392.1 ± 227.1 − 74.9 ± 1.5 − 56.6 ± 0.7 − 663.1 ± 34.8 − 818.0 ± 31.6
mCre4/rox − 542.3 ± 12.9 − 28,998.7 ± 289.4 28,939.4 ± 279.5 28,799.2 ± 281.9 − 76.1 ± 1.2 − 57.1 ± 0.6 − 677.8 ± 30.3 − 798.8 ± 26.1

ΔEvdW van der Waals energy, ΔEele columbic energy, ΔGGB Generalized-Born polar solvation energy, ΔGPB Poisson–Boltzmann polar solvation energy, ΔGSA(GB/PB) non-polar solvation energy from MM-GBSA/MM-PBSA.

The interaction energies obtained for the newly engineered Cre variants indicated that all the introduced mutations had a favorable effect on the molecular recognition of rox (mCre1: − 621.75/− 781.58, mCre2: − 619.15/− 771.85, mCre3: − 663.06/818.02 and mCre4: − 677.83/− 798.86 kcal/mol) compared to the native Dre/rox complex (Table 1). The binding energies of the new variants were not statistically very different from mCreK/rox, and the strongest contributions in all the cases were obtained from the net non-polar (netnpol) components (Table 1 and Fig. 6). We decided to perform the experimental validation of all the four variants against rox.

Figure 6.

Figure 6

Net free energy component analyses of the studied complexes; netpol(GB/PB): net polar contributions from MM-GBSA/MM-PBSA (netpol(GB/PB) = ΔEele + ΔGGB/PB), netnpol(GB/PB): net non-polar contributions from MM-GBSA/MM-PBSA (netnpol(GB/PB) = ΔEvdW + ΔGSA(GB/PB)).

Experimental validation of rationally engineered new Cre variants

To test the newly designed Cre variants (mCre1, mCre2, mCre3 and mCre4) experimentally, we introduced the corresponding mutations into the mCreK coding sequence. The sequences were confirmed by sequencing, and the recombinase mutants were cloned into the pEVOrox vector that allows regulated expression of the recombinase enzymes12. The vector also harbored two rox sites in direct orientation as an excision substrate (Fig. 7a), making it possible to investigate recombinase activity by the growth of the plasmids in bacteria at different l-arabinose concentrations followed by plasmid extraction, digestion and gel electrophoresis. Growing pEVOrox-mCreK at different l-arabinose concentrations confirmed that the three mutations introduced into Cre (K43R, R259P, G263K) conveyed recombination activity on the rox target sites, although partial recombination was only visible at high l-arabinose concentrations (Fig. 7b). Changing the threonine at position 258 to alanine (mCre1) or leucine (mCre2) slightly increased the recombination activity, but when the position 262 was changed to leucine in combination to L258 (mCre3), the recombination activity was completely lost. The loss in activity could be associated to the steric repulsions and poor interfacial interactions as observed through in silico analyses. Nevertheless, a remarkable increase in recombination activity was observed when position 262 was changed to Isoleucine in conjunction with A258 (mCre4). Indeed, full recombination of the plasmid was observed at the highest l-arabinose concentration for this variant (Fig. 7b), with increased recombination activity of up to 20-fold observed on the rox site when compared to mCreK (Supplementary Fig. S5). These data experimentally validate our structure-based rationale and MD simulation results, confirming that residues next to specificity-determining amino acids influence the activity of Cre-type site-specific recombinases.

Figure 7.

Figure 7

Rationally designed Cre mutants show increased recombination activity in E.coli. (a) Schematic drawing of the plasmid assay. Important regions in the plasmids are indicated. Note the reduced size of the plasmid after recombination. The restrictions sites (BsrGI and XbaI) used for cloning indicated Cre-recombinase variants are depicted. The rox target sites are shown as red triangles. CmR, chloramphenicol resistance gene; ori, origin of replication; AraC, arabinose operon regulatory gene. (b) Agarose gels of three independently picked clones showing BsrGI and XbaI digested plasmids carrying indicated recombinases. The amount of arabinose added to the growth medium is presented below each band in μg/ml l+-arabinose. The line with two triangles indicates no recombination, whereas the line with one triangle marks the recombined band. Quantifications of the ratios of band intensities (in percent of recombination) are shown to the right for each mutant. The amount of arabinose added to the growth medium is shown on the X-axis. Error bars depict standard deviation from the three independent experiments.

Conclusions

To better understand how Cre-type site-specific DNA recombinases may achieve better precision in terms of recombination activity, we investigated in detail the protein-DNA recognition properties of such recombinase systems in a comparative fashion by applying molecular modeling and dynamics simulations. Molecular dynamics simulations and binding energy calculations were used to examine by molecular and energetic means the mechanisms involved in DNA target recognition in the naturally occurring recombinase systems Cre/loxP and Dre/rox and the engineered variant mCreK. Although being able to recombine rox, mCreK exhibited low recombination activity, which made us consider a detailed analysis of the recognition properties of these recombinase systems in the region in which the specificity-determining residues are located (PDIBJ area) and to scrutinize at atomic level any aspect that may affect activity. The analysis of our theoretical molecular models and MD simulations pointed to neighbor amino acids of specificity-determining residues as relevant contributors to DNA target recognition and, therefore, as promising candidate positions to be exploited for the rational design of improved recombination activities. In particular, our MD-based analyses strongly emphasized on the relevance of having non-polar substitutions at positions 258 and 262 in the PDIBJ area, a feature not observed in naturally occurring SSRs. We established a rationale to account for the structure–function relationships, which we used to design new Cre variants predicted to have improved recombination activity on rox. The experimental validation of the newly designed Cre variants confirmed our predictions and supported the hypothesis that changes in the nature of amino acids spatially close to the specificity-determining residues could lead to enhance activities of engineered SSRs. This work demonstrates that computer-aided molecular modeling and simulation are valuable tools to build up innovative rational strategies for the efficient engineering of SSR systems with desired properties for applied site-specific recombination.

The results obtained should help for the future generation of designer-recombinases. Several amino acids in particular regions in Cre-like designer recombinases have been classified as implicated in the specificity of the enzymes28,37,39,40. DNA shuffling is currently used to combine beneficial mutations, thereby accelerating the directed evolution process. However, because DNA shuffling relies on the homology of DNA fragments, this method is not very efficient in combining residues that are close in sequence. Our results argue that amino acids that flank specificity-determining residues have an important role in obtaining SSRs with the highest activity. We, therefore, propose that targeted mutagenesis of nearest-neighbor amino acids of specificity-determining residues should be performed to optimize the activity of engineered SSRs.

Materials and methods

Molecular modeling and MD simulations

The crystal structure of the Cre/loxP complex was obtained from RCSB Protein Data Bank32 (PDB 1Q3U19, resolution 2.9 Å). This structure consists of four molecules of Cre and two of the loxP target site. For simplicity, in our modeling and dynamics simulations we have used half of the system (i.e. one loxP and two Cre molecules; cleaving and non-cleaving). This structure together with other available structural homologs at the Protein Data Bank (PDBs: 5U91, 1KBU, 3CRX) were used as a template to generate a 3D model of the Dre protein. For this, we used the comparative/homology modeling tool of Discovery Studio (DS version 3.5, https://www.3dsbiovia.com/)26 and MODELLER33,34 as implemented in DS. The SWISS-MODEL (version 1.0, https://swissmodel.expasy.org/)35 and PHYRE2 (version 2.0, https://www.sbg.bio.ic.ac.uk/)36 webservers with default values were also used in order to generate further 3D models of Dre. Likewise, the 3D model of the DNA target rox was generated using the loxP structure as a template with the modeling tool of DS. The Dre/rox complex was obtained by manual docking based on the superposition of the modeled Dre and rox molecules with the Cre/loxP structure while keeping the catalytic tyrosine and phosphate in close proximity. The 3D structures of all Cre mutant variants (mCreK, mCre1, mCre2, mCre3, and mCre4) were also obtained using the homology modeling tool of DS, and PDB 1Q3U was used as template. Similar manual docking procedures by superposition with the Cre/loxP structure were used to generate the 3D models of all Cre mutant variants in complex with the DNA targets (mCreK/loxP, mCreK/rox, mCre1/rox, mCre2/rox, mCre3/rox, and mCre4/rox). Hydrogen atoms were added to the complexes (including the wild type crystallographic structure of Cre/loxP) using the leap module of AMBER14 (https://ambermd.org/)41, and force-field parameters were assigned to the protein and DNA using ff14SB42 and parmbsc143 force-fields, respectively. Energy refinement of all complexes was carried out by using molecular dynamics (MD) simulations adopting ABC (Ascona B-DNA Consortium) protocols44,45.

MD simulations were performed on all the complexes with periodic boundary conditions in a truncated octahedral cell using the AMBER14 software suite41. The protein/DNA complexes were solvated with SPC/E46 water molecules, and charge neutrality was maintained by adding a sufficient number of potassium ions to the system. Simulations were conducted with 0.15 M KCl concentration using parameters from Dang47. Counterions were randomly placed initially in a cell, but no less than 5 Å away from DNA and 3.5 Å from one another. Electrostatics were handled using the Particle Mesh Ewald method48 with a cutoff of 10 Å. Lennard–Jones interactions were truncated at 9 Å. Initial energy minimization of the solvent (2,500 steepest descent and 2,500 conjugate gradient) was performed with harmonic restraints of 25 kcal mol−1 Å−2 on the solute, and then the minimization of solute–solvent was performed. Followed by minimization, equilibration was performed with slow heating of the solvent to 300 K at constant volume for a period of 200 ps, while restraining the solute atoms by 25 kcal mol−1 Å−2. These positional restraints were gradually removed from 5 to 1 kcal mol−1 Å−2 during the series of minimizations and equilibrations over a period of 1 ns. Finally, the production simulations were carried out initially for 100 ns using an NPT ensemble and the Berendsen algorithm49, which were later extended to 200 ns. All bonds involving hydrogen were constrained using SHAKE50.

Structural and energetic analyses of Protein–DNA molecular recognition

All the studied protein–DNA complexes remained structurally stable during the entire MD simulations as illustrated by the RMSD values obtained through the simulation time (Fig. S6). The structure-based analysis of the direct and indirect (water-mediated) hydrogen bonding established between the protein and DNA molecules in the studied complexes was done using the cpptraj51 module of AMBER14 and the WaterMap27 tool of Schrodinger (version 1.0, WaterMap, Schrödinger, 2019; https://www.schrodinger.com/). WaterMap is based on the inhomogeneous solvation theory, which analyses the results based on a short (2 ns) MD simulation. During MD, the complex is held rigid and water molecules are allowed to move. The clustering analysis is then performed on the population of water molecules to predict the location, and the free energy of each (favorable and unfavorable) water site is calculated. As the predictions are done on the population density of water molecules, the residence times of individual waters are not reported. Nucplot52 was also used for hydrogen bonding and van der Waals analyses. VMD53 was used for trajectory analysis. Pymol was used for the generation of figures (version 2.1, https://pymol.org/). The average K+ distribution analyses were performed using the Grid command of CPPTRAJ, AMBER14. The energetic analysis consisted of binding enthalpies calculated from the last 50 ns of the initial MD simulation using the MM-GB/PBSA38 module of AMBER (200 snapshots were used for calculations). The results represented in Table 1 and Fig. 6 belong to the initial 100 ns MD trajectory. The free energy analyses on the extended trajectory (100 ns to 200 ns) showed similar results (Table S3). The structural analyses performed for the extended simulations confirmed the interaction details obtained with the frames extracted from the initial MD trajectory and shown in Figs. 2, 3, 4 and 5.

Recombination assays in E. coli

For expression in E. coli, mCreK and variants thereof were cloned into the pEVOrox vector12 utilizing the unique BsrGI and XbaI (NEB, Ipswich, MA, USA) restriction sites. To introduce mutations into the mCreK coding sequence, site-directed mutagenesis was performed using the Q5 Site-Directed Mutagenesis Kit (NEB, Ipswich, MA, USA) following the manufacturer’s instructions. The expression of the recombinases from the pBAD promoter was induced with l-(+)-arabinose (Sigma-Aldrich Chemie GmbH). Single colonies of XL1-blue E.coli (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′ proABlacIqZ∆M15 Tn10 (Tetr)]; Agilent, Santa Clara, CA, USA) containing pEVOrox plasmid with the recombinase and recombination target sites were cultured overnight in 5 ml Luria broth (LB) medium with 30 μg/ml Cm and 0, 10, 100 or 1,000 μg/ml l-(+)-arabinose at 37 °C and 200 rpm before plasmid extraction, digestion, and gel electrophoresis. Gels were run to best separate the non-recombined forms and the recombined forms of the plasmids. The ca. 1 kb bands of the recombinase are therefore not visible in the gels in Fig. 7. Experiments were repeated with two additional clones and bands corresponding in size to the non-recombined and the recombined vector were quantified with Fiji–win64 software (ImageJ), respectively. The sum of non-recombined and recombined area was regarded as 100% and the fraction of non-recombined and recombined areas were calculated in percent. The standard deviations (STDDEV) of the 3 clones carrying the same mutations at identical l-(+)-arabinose induction levels were calculated.

Supplementary information

Acknowledgments

Authors gratefully acknowledge the technical support from Mario Hirt and Pedro Guillem Gloria, as well as the computational facilities at ZIH, Technische Universität Dresden. We are thankful to Dr. Gloria Ruiz-Gómez for valuable feedback and fruitful scientific discussions. Work in the Buchholz laboratory was supported by grants from the European Union (ERC 742133, H2020 UPGRADE 825825), the German Research Foundation (DFG BU 1400/7-1) and the BMBFGO-Bio 031B0633. Work in the Pisabarro group was partially funded by the German Research Foundation (DFG PI 600/4-1). The authors would like to dedicate this work to our IT especialists, health care professionals and many others on the frontlines whose great efforts are keeping all of us going during the Corona pandemic. Open access funding provided by Stockholm University.

Author contributions

A.S., F.B., M.T.P conceived and designed the project. A.S. performed the computational studies. M.A. performed the experiments. All authors analyzed the data and wrote the manuscript.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

is available for this paper at 10.1038/s41598-020-70867-5.

References

  • 1.Grindley NDF, Whiteson KL, Rice PA. Mechanisms of Site-specific recombination. Annu. Rev. Biochem. 2006;75:567–605. doi: 10.1146/annurev.biochem.73.011303.073908. [DOI] [PubMed] [Google Scholar]
  • 2.Jayaram M, Ma CH, Kachroo AH, Rowley PA, Guga P, Fan HF. An overview of tyrosine site-specific recombination: from an flp perspective. Microbiol Spectr. 2015;3:43–71.. doi: 10.1128/microbiolspec.MDNA3-0021-2014. [DOI] [PubMed] [Google Scholar]
  • 3.Kilby NJ, Snaith MR, Murray JAH. Site-specific recombinases: tools for genome engineering. Trends Genet. 1993;9:413–421. doi: 10.1016/0168-9525(93)90104-p. [DOI] [PubMed] [Google Scholar]
  • 4.Meinke G, Bohm A, Hauber J, Pisabarro MT, Buchholz F. Cre recombinase and other tyrosine recombinases. Chem. Rev. 2016;116:12785–12820. doi: 10.1021/acs.chemrev.6b00077. [DOI] [PubMed] [Google Scholar]
  • 5.Van Duyne GD. A structural view of Cre- loxP site-specific recombination. Annu. Rev. Biophys. Biomol. Struct. 2001;30:87–104. doi: 10.1146/annurev.biophys.30.1.87. [DOI] [PubMed] [Google Scholar]
  • 6.Sauer B. Inducible gene targeting in mice using the Cre/lox system. Methods. 1998;14:381–392. doi: 10.1006/meth.1998.0593. [DOI] [PubMed] [Google Scholar]
  • 7.Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis. 2000;26:99–109. [PubMed] [Google Scholar]
  • 8.Van Duyne GD. Cre recombinase. Microbiol. Spectr. 2014;3:119–138. doi: 10.1128/microbiolspec.MDNA3-0014-2014. [DOI] [PubMed] [Google Scholar]
  • 9.Anastassiadis K, et al. Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis. Model. Mech. 2009;2:508–515. doi: 10.1242/dmm.003087. [DOI] [PubMed] [Google Scholar]
  • 10.Suzuki E, Nakayama M. VCre/VloxP and SCre/SloxP: new site-specific recombination systems for genome engineering. Nucleic Acids Res. 2011;39:e49–e49. doi: 10.1093/nar/gkq1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Karimova M, et al. Vika/vox, a novel efficient and specific Cre/loxP-like site-specific recombination system. Nucleic Acids Res. 2013;41:e37–e37. doi: 10.1093/nar/gks1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Karimova M, Splith V, Karpinski J, Pisabarro MT, Buchholz F. Discovery of Nigri/nox and Panto/pox site-specific recombinase systems facilitates advanced genome engineering. Sci. Rep. 2016;6:30130. doi: 10.1038/srep30130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Karimova M, et al. A single reporter mouse line for Vika, Flp, Dre, and Cre-recombination. Sci. Rep. 2018;8:14453. doi: 10.1038/s41598-018-32802-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.He L, et al. Enhancing the precision of genetic lineage tracing using dual recombinases. Nat. Med. 2017;23:1488–1498. doi: 10.1038/nm.4437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yoshimura Y, et al. Novel reporter and deleter mouse strains generated using VCre/VloxP and SCre/SloxP systems, and their system specificity in mice. Transgenic Res. 2018;27:193–201. doi: 10.1007/s11248-018-0067-0. [DOI] [PubMed] [Google Scholar]
  • 16.Liu W, Tuck LR, Wright JM, Cai Y. Using purified tyrosine site-specific recombinases in vitro to rapidly construct and diversify metabolic pathways. Methods Mol. Biol. 2017;1:285–302. doi: 10.1007/978-1-4939-7169-5_18. [DOI] [PubMed] [Google Scholar]
  • 17.Lin Q, Qi H, Wu Y, Yuan Y. Robust orthogonal recombination system for versatile genomic elements rearrangement in yeast Saccharomycescerevisiae. Sci. Rep. 2015;5:15249. doi: 10.1038/srep15249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sauer B. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages. Nucleic Acids Res. 2004;32:6086–6095. doi: 10.1093/nar/gkh941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ennifar E. Crystal structure of a wild-type Cre recombinase-loxP synapse reveals a novel spacer conformation suggesting an alternative mechanism for DNA cleavage activation. Nucleic Acids Res. 2003;31:5449–5460. doi: 10.1093/nar/gkg732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Berezovsky IN, Chen WW, Choi PJ, Shakhnovich EI. Entropic stabilization of proteins and its proteomic consequences. PLoS Comput. Biol. 2005;1:e47. doi: 10.1371/journal.pcbi.0010047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kim S, Kim G, Lee Y, Park J. Characterization of Cre-loxP interaction in the major groove: hint for structural distortion of mutant Cre and possible strategy for HIV-1 therapy. J. Cell. Biochem. 2001;80:321–327. [PubMed] [Google Scholar]
  • 22.Meinke G, Karpinski J, Buchholz F, Bohm A. Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA. Nucleic Acids Res. 2017;45:9726–9740. doi: 10.1093/nar/gkx603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Karpinski J, et al. Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nat. Biotechnol. 2016;34:401–409. doi: 10.1038/nbt.3467. [DOI] [PubMed] [Google Scholar]
  • 24.Janin J. Wet and dry interfaces: the role of solvent in protein–protein and protein–DNA recognition. Structure. 1999;7:R277–R279. doi: 10.1016/s0969-2126(00)88333-1. [DOI] [PubMed] [Google Scholar]
  • 25.Reddy CK, Das A, Jayaram B. Do water molecules mediate protein-DNA recognition? J. Mol. Biol. 2001;314:619–632. doi: 10.1006/jmbi.2001.5154. [DOI] [PubMed] [Google Scholar]
  • 26.Discovery Studio 3.5, 2012. Accelrys Inc., San Diego, CA. https://www.accelrys.com.
  • 27.Young T, Abel R, Kim B, Berne BJ, Friesner RA. Motifs for molecular recognition exploiting hydrophobic enclosure in protein–ligand binding. Proc. Natl. Acad. Sci. 2007;104:808–813. doi: 10.1073/pnas.0610202104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Baldwin EP, et al. A specificity switch in selected cre recombinase variants is mediated by macromolecular plasticity and water. Chem. Biol. 2003;10:1085–1094. doi: 10.1016/j.chembiol.2003.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rufer AW. Non-contact positions impose site selectivity on Cre recombinase. Nucleic Acids Res. 2002;30:2764–2771. doi: 10.1093/nar/gkf399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Howerton SB, Sines CC, VanDerveer D, Williams LD. Locating monovalent cations in the grooves of B-DNA. Biochemistry. 2001;40(34):10023–10031. doi: 10.1021/bi010391+. [DOI] [PubMed] [Google Scholar]
  • 31.Lavery R, Maddocks JH, Pasi M, Zakrzewska K. Analyzing ion distributions around DNA. Nucleic Acids Res. 2014;42:8138–8149. doi: 10.1093/nar/gku504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Berman HM. The protein data bank. Nucleic Acids Res. 2000;28:235–242. doi: 10.1093/nar/28.1.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinform. 2016;54:5.6.1–5.6.37. doi: 10.1002/cpbi.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Šali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993;234:779–815. doi: 10.1006/jmbi.1993.1626. [DOI] [PubMed] [Google Scholar]
  • 35.Waterhouse A, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296–W303. doi: 10.1093/nar/gky427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The Phyre2 web portal for protein modeling, prediction and analysis. Nat. Protoc. 2015;10:845–858. doi: 10.1038/nprot.2015.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Abi-Ghanem J, et al. Engineering of a target site-specific recombinase by a combined evolution-and structure-guided approach. Nucleic Acids Res. 2013;41:2394–2403. doi: 10.1093/nar/gks1308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 2015;10:449–461. doi: 10.1517/17460441.2015.1032936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Hartung M, Kisters-Woike B. Cre mutants with altered DNA binding properties. J. Biol. Chem. 1998;273:22884–22891. doi: 10.1074/jbc.273.36.22884. [DOI] [PubMed] [Google Scholar]
  • 40.Santoro SW, Schultz PG. Directed evolution of the site specificity of Cre recombinase. Proc. Natl. Acad. Sci. 2002;99:4185–4190. doi: 10.1073/pnas.022039799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Case DA, et al. The Amber biomolecular simulation programs. J. Comput. Chem. 2005;26:1668–1688. doi: 10.1002/jcc.20290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Maier JA, et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 2015;11:3696–3713. doi: 10.1021/acs.jctc.5b00255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ivani I, et al. Parmbsc1: a refined force field for DNA simulations. Nat. Methods. 2016;13:55–58. doi: 10.1038/nmeth.3658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Pasi M, et al. μABC: a systematic microsecond molecular dynamics study of tetranucleotide sequence effects in B-DNA. Nucleic Acids Res. 2014;42:12272–12283. doi: 10.1093/nar/gku855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Lavery R, et al. A systematic molecular dynamics study of nearest-neighbor effects on base pair and base pair step conformations and fluctuations in B-DNA. Nucleic Acids Res. 2010;38:299–313. doi: 10.1093/nar/gkp834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Berendsen HJC, Grigera JR, Straatsma TP. The missing term in effective pair potentials. J. Phys. Chem. 1987;91:6269–6271. [Google Scholar]
  • 47.Dang LX. Mechanism and thermodynamics of ion selectivity in aqueous solutions of 18-crown-6 ether: a molecular dynamics study. J. Am. Chem. Soc. 1995;117:6954–6960. [Google Scholar]
  • 48.Essmann U, et al. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577–8593. [Google Scholar]
  • 49.Berendsen HJC, Postma JPM, Van Gunsteren WF, Dinola A, Haak JR. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984;81:3684. [Google Scholar]
  • 50.Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 1977;23:327–341. [Google Scholar]
  • 51.Roe DR, Cheatham TE. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 2013;9:3084–3095. doi: 10.1021/ct400341p. [DOI] [PubMed] [Google Scholar]
  • 52.Luscombe N. NUCPLOT: a program to generate schematic diagrams of protein-nucleic acid interactions. Nucleic Acids Res. 1997;25:4940–4945. doi: 10.1093/nar/25.24.4940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Humphrey W, Dalke A, Schulten KVMD. Visual molecular dynamics. J. Mol. Graph. 1996;14:33–38. doi: 10.1016/0263-7855(96)00018-5. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES